GGrantIndex
← Search

PHI-35: A PHASE I STUDY OF THE TOXICITIES, BIOLOGIC AND CLINICAL EFFECTS OF DAIL

$49,582M01FY2005RRNIH

University Of Southern California, Los Angeles CA

Investigators

Linked publications & trials

View original record on NIH RePORTER →
PHI-35: A PHASE I STUDY OF THE TOXICITIES, BIOLOGIC AND CLINICAL EFFECTS OF DAIL · GrantIndex